Clinical Trial Update: Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating Becotatug Vedotin with Pucotenlimab and Cisplatin in locally advanced head and neck squamous cell carcinoma; the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Becotatug Vedotin
• CISPLATIN (cisplatin)
• Pucotenlimab

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma HNSCC | Phase 2 | Status: NOT_YET_RECRUITING